NEW YORK CITY — Tishman Speyer, a New York-based owner and developer of trophy office assets around the world, plans to break ground in June on The Spiral, a $3.7 billion office tower that will rise 65 stories at 66 Hudson Blvd. in Manhattan. Global pharmaceutical company Pfizer recently signed an 800,000-square-foot, 20-year lease at The Spiral, which is slated for completion in 2022. Pfizer will occupy floors seven through 21, as well as some lobby space. The Spiral will serve as Pfizer’s new home, replacing its existing global headquarters at 235 E. 42nd St. in Manhattan. Blackstone Mortgage Trust Inc. (NYSE: BXMT) recently provided a $1.8 billion construction loan for the project. Tishman Speyer will finance the remaining $1.9 billion of development costs with its own equity, as well as financing from more than a dozen other institutional, pension fund and individual investors. Designed by BIG-Bjarke Ingels Group, each floor of The Spiral’s façade will feature landscaped terraces and hanging gardens that will be accessible to tenants. At one outdoor terrace per floor, the tower’s façade will be wrapped around by green space in a swirling pattern that serves as the tower’s signature element. The trophy office tower will …
